UNSPSC 51413909: Parodilol

This classification denotes a vasodilating agent with the molecular formula C23H27N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Q1O6G98Q8, chemically known as (- )-1-((2-indol-3-yl-1,1-dimethylethyl)amino)-3-(indol-4-yloxy)-2-propanol but generally known as parodilol, which bears US NIH Compound Identifier 3047816. European Medicines Agency schedules Parodilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09629MIG. The term PARODILOL is an International Non-Proprietary Name.

UNSPSC 51413909 Parodilol, a Commodity code, covers pharmaceutical products—specifically advanced life support medications and generic multi-source pharmaceuticals—that state and local governments procure for emergency medical services, public health programs, and employee health plans. State and local issuing bodies soliciting under this code include city fire departments and emergency services (Tampa Fire Rescue), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The work involves supplying branded and generic medications in specified quantities with strict expiration-date requirements, managing cold-chain logistics, and maintaining compliance with FDA regulations, cGMP standards, and the Drug Supply Chain Security Act. Vendors typically furnish products through authorized wholesalers, submit detailed National Drug Code and product specifications, warrant product quality for a minimum of 12 months, and arrange pickup and replacement of expired stock before contract expiration.

Recent opportunities span Texas, Minnesota (with Oregon participating through the cooperative), and Florida. The City of Tampa's Purchasing Department issued an Invitation for Bid (IFB) in April 2026 for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026, estimated value $40,000) requiring delivery of Labetalol HCI, Epinephrine, Adenosine, and Diltiazem to Tampa Fire Rescue with a one-year initial term and two renewal options. The Minnesota Department of Administration's Office of State Procurement issued an RFP through MMCAP (Solicitation S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with contract effectiveness July 1, 2026, and a two-year initial term. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013, due April 3, 2026) to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling exploratory procurement activity ahead of a formal RFP. Tampa's solicitation included a 5 percent bid discount for Small Local Business Enterprise participation and required WCAG 2.2 Level AA accessibility documentation and OSHA-compliant Safety Data Sheets.